Iceland· IS-EU/1/19/1410/001-006
Spravato
A esketamine product containing esketaminum inn,esketaminum inn hýdróklóríð, registered in Iceland by Janssen-Cilag International NV*. The same ATC class is registered in 11 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Esketamine is registered in 11 of 19 countries.
Countries holding a registration under ATC N06AX27 (esketamine), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 7 of them publish a price we can compare per daily dose
Esketamine · ATC N06AX27
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of esketamine costs, country by country.
Normalised to the WHO defined daily dose (8 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Esketamine · price per daily dose (8 mg)
USD · FX 28 Sept 2026
- CH Switzerland$66.47
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Esketaminum INN,Esketaminum INN hýdróklóríð
- Manufacturer
- Janssen-Cilag International NV*
- Country
- Iceland (IS)
- ATC code
- N06AX27
- ATC class
- Esketamine
- Defined daily dose
- 8 mg, N
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 1
1 priced- ean04077128 mg x3 úðaíláISK 110023
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
91 interactions on record for esketamine.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Esketamine · interactions on record
91 records
- 7 severe
- 84 moderate
Most severe, free to view
- PhentermineA08AA01severe
- FenfluramineA08AA02severe
- MazindolA08AA05severe
- FenfluramineN03AX26severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Esketamine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandEsketamine KalceksAS Kalceks
- NetherlandsEsketamine 5 mg/ml Focus, oplossing voor injectie / infusieFocus Care Pharmaceuticals B.V.
- GermanyEsketaminInresa Arzneimittel Gmbh
- United KingdomEsketamine 250mg/10ml solution for injection ampoulesAS Kalceks
- SwedenEsketamine Kalceks 25 mg/ml Injektions-/infusionsvätska, lösningAS KALCEKS
- BelgiumEsketamine Kalceks 25 mg/mlKalceks
- SwitzerlandEsketamin Sintetica 25 mg/ml, soluzione iniettabile o per infusioneSintetica SA
- CzechiaSPRAVATOJanssen-Cilag International N.V., Beerse
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Austria · Escetex, Eskelan
- Belgium · Esketamine Kalceks, Vesierra
- Germany · Esketamin, Esketamin Inresa
- Denmark · Esketamine Orifarm, S-Ketamin Pfizer
- Estonia · Esketex
- Finland · Esketamine Kalceks, Esketamine Orifarm
- France · Eskesia, Esketamine Renaudin
- United Kingdom (Northern Ireland) · Esketamine Idd, Esketamine Kalceks
- Croatia · Esgamda
- Liechtenstein · Spravato
- Luxembourg · Vesierra
- Latvia · Esketamine Kalceks
- Netherlands · Esketamine Focus, Esketamine Idd
- Norway · Ketanest, Sinmelan
- Sweden · Esketamine Kalceks, Esketamine Orifarm
- Slovenia · Esketamin Kalceks, Sinmelan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4b3f7c59-63b0-4ec9-99e2-0e044c174edb GET /v1/drugs/4b3f7c59-63b0-4ec9-99e2-0e044c174edb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Nefúði, lausn",
"source": "lyfjastofnun",
"atc_raw": "N06AX27",
"marketed": true,
"strength": "28 mg",
"ma_number": "EU/1/19/1410/001-006",
"substance": "Esketaminum INN,Esketaminum INN hýdróklóríð",
"other_info": "Markaðssetning á Íslandi er háð því að Lyfjastofnun hafi staðfest að sérstök skilyrði er varða öryggi og verkun við notkun lyfsins séu uppfyllt.",
"legal_status": "(R X) Eftirritunarskylt (og lyfseðilsskylt)\r\n(H) Sjúkrahúsmerkt",
"ma_issued_serial": "43817"
}See everything about esketamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.